News Conference News THT 2024 Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS Michael O'Riordan March 06, 2024
News Daily News More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis L.A. McKeown February 12, 2024
News Daily News Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help Todd Neale January 11, 2024
News Daily News Daily Texts Boost Self-care in HFrEF but Don’t Impact Outcomes L.A. McKeown December 08, 2023
News Conference News AHA 2023 Seeing Sticker Price for HFrEF Meds Opens Door to Discussions Caitlin E. Cox November 14, 2023
News Conference News AHA 2023 DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI Shelley Wood November 11, 2023
News Conference News HFSA 2023 STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization L.A. McKeown October 18, 2023
News Conference News HFSA 2023 Survey Offers Clues to Waning Appeal of Acute HF/Transplant Fellowships Shelley Wood October 13, 2023
News Conference News HFSA 2023 Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis Todd Neale October 11, 2023
News Daily News Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry Michael O'Riordan September 27, 2023
News Daily News Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All Michael O'Riordan September 18, 2023
News Daily News Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability Todd Neale September 13, 2023
News Conference News ESC 2023 ESC Focused Update on HF Synthesizes New Trial Data for Practical Use L.A. McKeown September 01, 2023
News Conference News ESC 2023 Early SGLT2 Inhibition, Spot Urine Sodium Checks May Help in Acute HF Todd Neale September 01, 2023